Home/ Stocks/ LENZ

LENZ Therapeutics, Inc. Common Stock

LENZ XNAS

$9.03 -1.95 (-17.73%) ▼ 15-min delayed

Open

$10.47

High

$10.47

Low

$8.85

Volume

3.91M

Market Cap

$344.19M

About LENZ Therapeutics, Inc. Common Stock

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 42 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$12.50M	$-16,700,000	$-0.59
Q2 2025	$5.00M	$-14,912,000	$-0.53
Q1 2025	$0	$-14,619,000	$-0.53
FY 2024	$0	$-49,769,000	$-2.34

Related Market News

No specific coverage for LENZ yet. Check out our latest market news or earnings calendar.

Get LENZ Alerts

Stay ahead with breaking news, price alerts, and expert analysis on LENZ Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.